Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 5.55 USD -3.31% Market Closed
Market Cap: 111m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Journey Medical Corp
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Journey Medical Corp
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Journey Medical Corp
NASDAQ:DERM
Other Current Assets
$3.6m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Current Assets
$4.2B
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Other Current Assets
$1.8B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
-2%
Pfizer Inc
NYSE:PFE
Other Current Assets
$4.2B
CAGR 3-Years
-18%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Other Current Assets
$7.4B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Other Current Assets
$8.4B
CAGR 3-Years
40%
CAGR 5-Years
29%
CAGR 10-Years
26%
No Stocks Found

Journey Medical Corp
Glance View

Market Cap
115m USD
Industry
Pharmaceuticals

Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. The company is headquartered in Scottsdale, Arizona and currently employs 90 full-time employees. The company went IPO on 2021-11-12. The company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company provides nine products that help treat and heal common skin conditions, such as Qbrexza, Accutane, Targadox, Ximino, Exelderm Cream and Solution, Ceracade Skin Emulsion, Luxamend Wound Cream, AMZEEQ and ZILXI. Its product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne; Exelderm Cream and Solution is an antifungal intended for topical use; Ceracade Skin Emulsion is used to treat dry skin conditions; AMZEEQ is used for the treatment of acne and ZILXI, for the treatment of rosacea.

DERM Intrinsic Value
4.22 USD
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Journey Medical Corp's Other Current Assets?
Other Current Assets
3.6m USD

Based on the financial report for Dec 31, 2023, Journey Medical Corp's Other Current Assets amounts to 3.6m USD.

What is Journey Medical Corp's Other Current Assets growth rate?
Other Current Assets CAGR 3Y
28%

Over the last year, the Other Current Assets growth was 9%. The average annual Other Current Assets growth rates for Journey Medical Corp have been 28% over the past three years .

Back to Top